Protein C and Fibrinolysis: A Link between Coagulation and Fibrinolysis

  • N. J. de Fouw
  • F. Haverkate
  • R. M. Bertina
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 281)


The effect of purifed human activated protein C (APC) on fibrinolysis was studied by using in vitro clot lysis techniques. Clots were formed from citrated blood or plasma (supplemented with 125I-labeled fibrinogen) by adding thrombin and Ca2+-ions; lysis of the clots was achieved by the addition of tissue-type plasminogen activator before clot formation. The gradual release of labeled fibrin degradation products from the clot into the supernatant was taken as a measure for the lysis rate. It was demonstrated that the acceleration of clot lysis by APC added before clot formation depends on the presence of Protein S, Ca2+-ions and phospholipids. These observations suggest a role of APC as anticoagulant in clot lysis, since the cofactors for the expression of its anticoagulant and profibrinolytic effect are very similar. Indeed, we could demonstrate that the profibrinolytic effect of APC in vitro is associated with reduction of thrombin generation through the coagulation cascade by inactivation of factor VIIIa and factor Va. For instance, APC did not accelerate the lysis of factor X deficient blood clots.

More generally, thrombin generation was associated with retarded fibrinolysis in vitro. Consequently anticoagulants such as APC or Heparin are profibrinolytic, whereas pro-coagulants such as phospholipids (in cell-free plasma) inhibit fibrinolysis through the generation of thrombin. Thrombin thus plays a crucial role as a link between coagulation and fibrinolysis. As thrombin is able to inhibit the lysis of blood and plasma clots, and not of purified fibrin clots, we hypothesize that thrombin inhibits lysis through an as yet unidentified mediator in plasma.


Thrombin Generation Clot Formation Clot Lysis Lysis Rate Recalcification Time 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bertina, R. M., Broekmans, A. W., Van de Linden, I. K., and Mertens, K., 1982, Protein C deficiency in a Dutch family with thrombotic disease, Thromb. Haemostas., 48:1.Google Scholar
  2. Bertina, R. M., Broekmans, A. W., Krommenhoek-Van Es, C., and Van Wijngaarden, A., 1984, The use of a functional and immunological assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency, Thromb. Haemostas., 15:1.Google Scholar
  3. Burdick, M. D., and Schaub, R. G., 1987, Human activated protein C produces anticoagu- lation and increased fibrinolytic activity in the cat, Thromb. Res., 45:413.PubMedCrossRefGoogle Scholar
  4. Clauss, A., 1957, Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens, Acta Haematol. (Basel), 17:237.PubMedCrossRefGoogle Scholar
  5. Colucci, M., Stassen, J. M., and Collen, D., 1984, Influence of protein C activation on blood coagulation and fibrinolysis in squirrel monkeys, J. Clin. Invest., 74:200.PubMedCrossRefGoogle Scholar
  6. Comp, P. C., and Esmon, C. T., 1981, Generation of fibrinolytic activity by infusion of activated protein C into dogs, J. Clin. Invest., 68:1221.PubMedCrossRefGoogle Scholar
  7. D’Angelo, A., Lockhart, M. S., D’Angelo, S. V., and Taylor, F. B., 1987, Protein S is a cofactor for activated protein C neutralization of an inhibitor of plasminogen activator released from platelets, Blood, 69:231.PubMedGoogle Scholar
  8. De Fouw, N. J., Haverkate, F., Bertina, R. M., Koopman, J., Van Wijngaarden, A., and Van Hinsbergh, V. W. M., 1986, The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro, Blood, 67(4):1189.PubMedGoogle Scholar
  9. De Fouw, N. J., Van Hinsbergh, V. W. M., De Jong, Y. F., Haverkate, F., and Bertina, R. M., 1987, The interaction of activated protein C and thrombin with the plasminogen activator inhibitor released from cultured endothelial cells, Thromb. Haemostas., 57: 176.Google Scholar
  10. De Fouw, N. J., De Jong, Y. F., Haverkate, F., and Bertina, R. M., 1988a, Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor; no evidence for a cofactor role of protein S, Thromb. Haemostas., 60(2):328.Google Scholar
  11. De Fouw, N. J., De Jong, Y. F., Haverkate, F., and Bertina, R, M., 1988b, The influence of thrombin and platelets on fibrin clot lysis rates in vitro. A study using a clot lysis system consisting of purified human proteins, Fibrinolysis, 2:235.Google Scholar
  12. Erickson, L. A., Ginsberg, M. H., and Loskutoff, D. J., 1984, Detection and partial characterization of an inhibitor of plasminogen activator in human platelets, J. Clin. Invest., 74:1465.PubMedCrossRefGoogle Scholar
  13. Esmon, C. T., and Esmon, N. L., 1984, Protein C activation, Sem. Thromb. Haemostas., 10:122.CrossRefGoogle Scholar
  14. Fay, W. P., and Owen, W. G., 1989, Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C, Biochemistry, 28:5773.PubMedCrossRefGoogle Scholar
  15. Folch, L., Lees, M., and Sloane, S. G. H., 1957, A simple method for the isolation and purification of total lipids from animal tissues, J. Biol. Chem., 226:497.PubMedGoogle Scholar
  16. Fraker, P. J., and Speck, J. C., 1978, Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a, 6a-diphenyl-glycoluril, Biochem. Biophys. Res. Commun., 80:849.PubMedCrossRefGoogle Scholar
  17. Fulcher, C. A., Gardiner, J. E., Griffin, J. H., and Zimmerman, T. S., 1984, Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V, Blood, 63:486.PubMedGoogle Scholar
  18. Haverkate, F., and Brakman, P., 1975, Fibrin plate assay, in: “Progress in Chemical Fibrinolysis and Thrombolysis”, J. F. Davidson, M. M. Samama, P. C. Desnoyers, eds., Raven Press, New York, Vol. 1, p. 151.Google Scholar
  19. Jansen, J. W. C. M., Haverkate, F., Koopman, J., Nieuwenhuis, H. K., Kluft, C., and Boschman, Th. A. C., 1987, Influence of factor XIIIa activity on human whole blood clot lysis in vitro, Thromb. Haemostas., 72:171.Google Scholar
  20. Kluft, C., Wijngaards, G., Jie, A. F. H., and Groeneveld, E. 1985, Appropriate milieu for the assay of α2-antiplasmin activity with chromogenic substrates, Haemostasis, 15:198.PubMedGoogle Scholar
  21. Kluft, C., Nieuwenhuis, H. K., Rijken, D. C., Groeneveld, E., Wijngaards, G., Van Berkel, N., Dooijewaard, G., and Sixma, J. J., 1987, α2-Anti-plasmin Enschede: dysfunc-tional α2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder, J. Clin. Invest., 80:1391.PubMedCrossRefGoogle Scholar
  22. Rijken, D. C., Wijngaards, G., Zaal-de Jong, M., and Welbergen, J., 1979, Purification and partial characterization of plasminogen activator from human uterine tissue, Biochim. Biophys. Acta, 580:140.PubMedCrossRefGoogle Scholar
  23. Rijken, D. C., Wijngaards, G., and Welbergen, J., 1980, Relationship between tissue plasminogen activator and the activators in blood and vascular wall, Thromb. Res., 18:815.PubMedCrossRefGoogle Scholar
  24. Sakata, Y., and Aoki, N., 1980, Crosslinking of α2 antiplasmin inhibitor to fibrin by fibrin-stabilizing factor, J. Clin. Invest., 65:290.PubMedCrossRefGoogle Scholar
  25. Sakata, Y., Curriden, S., Lawrence, D., Griffin, J. H., and Loskutoff, D. J., 1985, Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity, Proc. Natl. Acad. Sci. USA,82:1121.PubMedCrossRefGoogle Scholar
  26. Sprengers, E. D., Akkerman, J. W. N., and Jansen, B. G., 1986, Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator in human blood. Thromb. Haemostas., 55:325.Google Scholar
  27. Taylor Jr, F. B., and Lockhart, M. S., 1985a, Whole blood clot lysis: in vitro modulation by activated protein C, Thromb. Res., 37:639.CrossRefGoogle Scholar
  28. Taylor Jr, F. B., and Lockhart, M. S., 1985b, A new function for activated protein C: APC prevents inhibition of plasminogen activators by release from mononuclear leukocytes-platelet suspensions stimulated by phorboldiester, Thromb. Res., 37:155.CrossRefGoogle Scholar
  29. Van Hinsbergh, V. W. M., Bertina, R. M., Van Wijngaarden, A., Van Tilburg, N. H., Emeis, J. J., and Haverkate, F., 1985, Activated protein C decreases plasminogen activator activity in endothelial cell conditioned medium, Blood, 65:444.PubMedGoogle Scholar
  30. Van Ruijven-Vermeer, I. A. M., and Nieuwenhuizen, W., 1978, Purification of rat fibrinogen and its constituent chains, Biochem. J., 169:653.PubMedGoogle Scholar
  31. Verheijen, J. H., Mullaart, E., Chang, G. T. G., Kluft, C., and Wijngaards, G., 1982, A simple, sensitive spectrophotometric assay for extrinsic (tissue type) plasminogen activator applicable to measurements in plasma, Thromb. Haemost.,48:266.PubMedGoogle Scholar
  32. Walker, F. J., 1981, Regulation of activated protein C by protein S. The role of phospholipids in factor Va inactivation, J. Biol. Chem., 256:11128.PubMedGoogle Scholar
  33. Zolton, R. P., Seegers, W. H., 1973, Autoprothrombin II-A: Thrombin removal and mechanism of induction of fibrinolysis, Thromb. Res., 3:23.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • N. J. de Fouw
    • 1
    • 2
  • F. Haverkate
    • 1
  • R. M. Bertina
    • 2
  1. 1.Gaubius Institute TNOLeidenThe Netherlands
  2. 2.University Hospital LeidenThe Netherlands

Personalised recommendations